Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:48
Precision BioSciences Net Income (Quarterly) : -7.586M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.586M |
| June 30, 2026 | -32.65M |
| March 31, 2026 | -18.44M |
| December 31, 2025 | 19.25M |
| September 30, 2025 | -21.77M |
| June 30, 2025 | -23.52M |
| March 31, 2025 | -20.56M |
| December 31, 2024 | -17.74M |
| September 30, 2024 | -16.42M |
| June 30, 2024 | 32.75M |
| March 31, 2024 | 8.588M |
| December 31, 2023 | -13.43M |
| September 30, 2023 | -12.11M |
| June 30, 2023 | -3.033M |
| March 31, 2023 | -13.95M |
| December 31, 2022 | -19.43M |
| September 30, 2022 | -15.69M |
| Date | Value |
|---|---|
| June 30, 2022 | -31.04M |
| March 31, 2022 | -28.17M |
| December 31, 2021 | -22.29M |
| September 30, 2021 | -11.28M |
| June 30, 2021 | 21.66M |
| March 31, 2021 | -18.69M |
| December 31, 2020 | -23.45M |
| September 30, 2020 | -26.02M |
| June 30, 2020 | -32.70M |
| March 31, 2020 | -26.84M |
| December 31, 2019 | -20.92M |
| September 30, 2019 | -20.74M |
| June 30, 2019 | -19.44M |
| March 31, 2019 | -31.78M |
| December 31, 2018 | -15.44M |
| March 31, 2018 | -9.012M |
| December 31, 2017 | -7.382M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.586M |
| EPS Diluted (Quarterly) | -0.2765 |
| Enterprise Value | 221.18M |
| Earnings Yield | -13.01% |
| Normalized Earnings Yield | -13.87 |